Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Sectors

QinBaoBao clinches series D funding

The Fosun and TAL Education-backed parenting app developer has secured $38.6m from two China-based venture capital firms.


Jan 7, 2021

IQiyi Intelligent gets series B influx

The VR and AR technology developer, which was spun off by iQiyi, has closed an eight-figure series B round co-led by Yitang Changhou Fund and Fresh Capital.

Jan 7, 2021

Investors hook up Hinge Health with $300m

IP Group portfolio company Hinge Health has pushed its valuation to $3bn following a $300m series D round co-led by Coatue Management and Tiger Global.

Jan 7, 2021

Volta Medical sparks $28m round

Existing investor Pasteur Mutualité came back for a round that will precede a trial of Volta's software, which helps in the treatment of cardiac arrythmias.

Jan 7, 2021

GB News gees itself up with investment

Discovery has provided about a third of the $81.7m closed by GB News as it prepares to launch its right-wing current affairs channel later this year.

Jan 7, 2021

GoBear to shut down despite recent funding

The Aegon-backed loan and insurance comparison platform will shut down after raising $97m in the past two years.

Jan 6, 2021

Creditas looks to house Bcredi acquisition

Creditas will pay an undisclosed amount for the digital mortgage lender, a spinoff from Banco Bari, as it seeks to boost its real estate financing division.

Jan 6, 2021

AMP Robotics accesses $55m in series B

UC-backed Congruent Ventures has contributed to a $55m round that will support the recycling robot maker's expansion plans.

Jan 6, 2021

Udaan ups series D round to $865m

Tencent was among the investors that added $280m to the business e-commerce marketplace's series D round, valuing it at $3.1bn.

Jan 6, 2021

Divvy bills investors for $165m series D

The expense management technology provider has secured funding from investors including Hanaco and PayPal Ventures at a $1.6bn valuation.

Jan 6, 2021

Boan Biotech banks $106m

The antibody drug developer, majority owned by Luye Pharma, pushed its valuation past $850m in a round backed by Bank of China’s BOCG vehicle.

Jan 6, 2021

Terns earns $87m in series C round

Eli Lilly invested directly and through its Lilly Asia Ventures fund, in a round that brought liver disease-focused drug developer Terns' overall funding to $197m.

Jan 6, 2021
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here